{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:36:59Z","timestamp":1786736219002,"version":"build-2736575974"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijc.ijc_349_17","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T05:45:40Z","timestamp":1567143940000},"page":"566","source":"Crossref","is-referenced-by-count":10,"title":["Effect of levamisole on expression of CD138 and interleukin-6 in human multiple myeloma cell lines"],"prefix":"10.4103","volume":"54","author":[{"given":"B","family":"Nageshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramchander","family":"Merugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.233150-1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0019-509X.233150-2","doi-asserted-by":"crossref","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. In Mayo Clinic Proceedings. Vol. 78. No 1: Elsevier; 2003. p. 21-33.","DOI":"10.4065\/78.1.21"},{"key":"key-10.4103\/0019-509X.233150-3","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","article-title":"Functions of cell surface heparan sulfate proteoglycans","author":"Bernfield","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"key-10.4103\/0019-509X.233150-5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI200113560","article-title":"Series introduction: Heparan sulfate proteoglycans: Intricate molecules with intriguing functions","author":"Iozzo","year":"2001","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0019-509X.233150-6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI200113738","article-title":"Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena","author":"Iozzo","year":"2001","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0019-509X.233150-7","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V91.8.2679.2679_2679_2688","article-title":"Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation","author":"Dhodapkar","year":"1998","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-8","first-page":"3","article-title":"IL-6 as a growth factor for human multiple myeloma cells \u2013 A short overview","author":"Nilsson","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"key-10.4103\/0019-509X.233150-9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/stem.5530090303","article-title":"Interleukin 6 (IL-6) and its receptor: Their role in plasma cell neoplasias","author":"Hirano","year":"1991","journal-title":"Int J Cell Cloning"},{"key":"key-10.4103\/0019-509X.233150-10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/cbir.2000.0497","article-title":"Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma","author":"Gad\u00f3","year":"2000","journal-title":"Cell Biol Int"},{"key":"key-10.4103\/0019-509X.233150-11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/cimm.1995.1076","article-title":"Interleukin-6 inhibits apoptosis of malignant plasma cells","author":"Lichtenstein","year":"1995","journal-title":"Cell Immunol"},{"key":"key-10.4103\/0019-509X.233150-12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO;2-Q","article-title":"The biological effects of interleukin 6","author":"Barton","year":"1996","journal-title":"Med Res Rev"},{"key":"key-10.4103\/0019-509X.233150-13","first-page":"237","article-title":"Inhibiting IL-6 in human multiple myeloma","author":"Klein","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"key-10.4103\/0019-509X.233150-14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V85.4.863.bloodjournal854863","article-title":"Interleukin-6 in human multiple myeloma","author":"Klein","year":"1995","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/332083a0","article-title":"Autocrine generation and requirement of BSF-2\/IL-6 for human multiple myelomas","author":"Kawano","year":"1988","journal-title":"Nature"},{"key":"key-10.4103\/0019-509X.233150-16","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V81.12.3357.3357","article-title":"Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells","author":"Hata","year":"1993","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-17","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V84.9.3063.3063","article-title":"Interleukin-6 prevents dexamethasone-induced myeloma cell death","author":"Hardin","year":"1994","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.V89.1.227","article-title":"Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells","author":"Chauhan","year":"1997","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-19","first-page":"35","article-title":"Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells","author":"Chauhan","year":"1995","journal-title":"Stem Cells"},{"key":"key-10.4103\/0019-509X.233150-20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.onc.1201253","article-title":"Dexamethasone induces apoptosis of multiple myeloma cells in a JNK\/SAP kinase independent mechanism","author":"Chauhan","year":"1997","journal-title":"Oncogene"},{"key":"key-10.4103\/0019-509X.233150-21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-22","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V84.7.2269.2269","article-title":"Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures","author":"Lokhorst","year":"1994","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-23","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","article-title":"Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion","author":"Uchiyama","year":"1993","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114392","article-title":"Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias","author":"Bataille","year":"1989","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0019-509X.233150-25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF01714900","article-title":"Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: Correlation with disease activity and other prognostic parameters","author":"Nachbaur","year":"1991","journal-title":"Ann Hematol"},{"key":"key-10.4103\/0019-509X.233150-26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428199609051732","article-title":"Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia","author":"Reittie","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/0019-509X.233150-27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000225546","article-title":"Levamisole and immunotherapy: Some theoretic and practical considerations and their relevance to human disease","author":"Amery","year":"1981","journal-title":"Oncology"},{"key":"key-10.4103\/0019-509X.233150-28","first-page":"167","article-title":"Levamisole in the treatment of stage II breast cancer five-year follow-up of a randomized double-blind study","author":"Amery","year":"1997","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0019-509X.233150-29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jnci\/84.7.515","article-title":"Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase","author":"Kovach","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0019-509X.233150-30","first-page":"162","article-title":"Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil","author":"de","year":"1998","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-509X.233150-31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jcb.240400212","article-title":"Competitive, uncompetitive, and mixed inhibitors of the alkaline phosphatase activity associated with the isolated brush border membrane of the tapeworm Hymenolepis diminuta","author":"Pappas","year":"1989","journal-title":"J Cell Biochem"},{"key":"key-10.4103\/0019-509X.233150-32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjp.0703660","article-title":"Levamisole induced apoptosis in cultured vascular endothelial cells","author":"Artwohl","year":"2000","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0019-509X.233150-33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4049\/jimmunol.129.1.52","article-title":"Alkaline phosphatase activity as a membrane marker for activated B cells","author":"Garc\u00eda-Rozas","year":"1982","journal-title":"J Immunol"},{"key":"key-10.4103\/0019-509X.233150-34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1248\/bpb1978.9.593","article-title":"Induction of alkaline phosphatase activity in murine spleen cells treated with various mitogens","author":"Ohno","year":"1986","journal-title":"J Pharmacobiodyn"},{"key":"key-10.4103\/0019-509X.233150-35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.142.2.381","article-title":"Late events in B cell activation.Expression of membrane alkaline phosphatase activity","author":"Burg","year":"1989","journal-title":"J Immunol"},{"key":"key-10.4103\/0019-509X.233150-36","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.4049\/jimmunol.142.9.3187","article-title":"Expression of alkaline phosphatase in murine B lymphocytes.Correlation with B cell differentiation into Ig secretion","author":"Marquez","year":"1989","journal-title":"J Immunol"},{"key":"key-10.4103\/0019-509X.233150-37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-2478(93)90172-X","article-title":"Effect of anti-alkaline phosphatase monoclonal antibody on B lymphocyte function","author":"Marty","year":"1993","journal-title":"Immunol Lett"},{"key":"key-10.4103\/0019-509X.233150-38","first-page":"505","article-title":"Interleukin-5 increases the expression of alkaline phosphatase activity in murine B lymphocytes","author":"Souvannavong","year":"1992","journal-title":"Immunology"},{"key":"key-10.4103\/0019-509X.233150-39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","article-title":"Can biological classification occur in the presence of pyrophosphate?","author":"Meyer","year":"1984","journal-title":"Arch Biochem Biophys"},{"key":"key-10.4103\/0019-509X.233150-40","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1038\/bcj.2014.82","article-title":"Hypoxia promotes stem cell-like phenotype in multiple myeloma cells","author":"Muz","year":"2014","journal-title":"Blood Cancer J"},{"key":"key-10.4103\/0019-509X.233150-41","first-page":"443","article-title":"The Strychnosnux-vomica root extract induces apoptosis in the human multiple myeloma cell line-U266B1.Cell Biochemistry and Biophysics","author":"Rao","year":"2013","journal-title":""},{"key":"key-10.4103\/0019-509X.233150-42","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.4161\/cc.7.20.6832","article-title":"Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells","author":"Malara","year":"2008","journal-title":"Cell Cycle"},{"key":"key-10.4103\/0019-509X.233150-43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/CAD.0b013e32830c236a","article-title":"Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells","author":"Park","year":"2008","journal-title":"Anticancer Drugs"},{"key":"key-10.4103\/0019-509X.233150-44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2008-04-151928","article-title":"SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK","author":"Okawa","year":"2009","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yexcr.2008.11.007","article-title":"The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma","author":"Baumann","year":"2009","journal-title":"Exp Cell Res"},{"key":"key-10.4103\/0019-509X.233150-46","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1158\/1078-0432.CCR-08-0457","article-title":"Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells","author":"Garcia-Bates","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0019-509X.233150-47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling","author":"Hunter","year":"1995","journal-title":"Cell"},{"key":"key-10.4103\/0019-509X.233150-48","unstructured":"Wijdenes J, Clement C, Klein B, Dore J. CD138 cluster report. In: Kishimoto T, editor. Leukocyte Typing VI: Proceedings of the Sixth International Workshop and Conference on Human Leukocyte Differentiation Antigens. New York: Garland; 1996. p. 249-52."},{"key":"key-10.4103\/0019-509X.233150-49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0167-5699(93)90265-M","article-title":"Role of heparan sulfate in immune system-blood vessel interactions","author":"Ihrcke","year":"1993","journal-title":"Immunol Today"},{"key":"key-10.4103\/0019-509X.233150-50","doi-asserted-by":"crossref","first-page":"14713","DOI":"10.1074\/jbc.272.23.14713","article-title":"Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation","author":"Subramanian","year":"1997","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0019-509X.233150-51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj3190039","article-title":"Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1","author":"Reiland","year":"1996","journal-title":"Biochem J"},{"key":"key-10.4103\/0019-509X.233150-52","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0959-8049(97)00248-7","article-title":"Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia","author":"Sebesty\u00e9n","year":"1997","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-509X.233150-53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/cimm.1994.1042","article-title":"Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells","author":"Sneed","year":"1994","journal-title":"Cell Immunol"},{"key":"key-10.4103\/0019-509X.233150-54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1998.00623.x","article-title":"The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells","author":"Jourdan","year":"1998","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0019-509X.233150-55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1074-7613(00)80387-8","article-title":"Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation","author":"Altmeyer","year":"1997","journal-title":"Immunity"},{"key":"key-10.4103\/0019-509X.233150-56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(00)80241-1","article-title":"Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6","author":"Morse","year":"1997","journal-title":"Immunity"},{"key":"key-10.4103\/0019-509X.233150-57","first-page":"255","article-title":"Heterogeneity in response to interleukin 6 (IL-6), exression of IL-6 and IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines","author":"Jernberg","year":"1991","journal-title":"Leukemia"},{"key":"key-10.4103\/0019-509X.233150-58","first-page":"696","article-title":"Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.Journal of Clinical Investigation","author":"Levy","year":"1991","journal-title":""},{"key":"key-10.4103\/0019-509X.233150-59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V77.3.587.587","article-title":"Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266","author":"Schwab","year":"1991","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.233150-60","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1172\/JCI115355","article-title":"Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines","author":"Levy","year":"1991","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0019-509X.233150-61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/1547691X.2010.514871","article-title":"Anti-proliferative effect of levamisole on human myeloma cell lines in vitro","author":"Ramanadham","year":"2010","journal-title":"J Immunotoxicol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:00Z","timestamp":1786732740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_349_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["233150"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_349_17","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}